Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorNombre químico: Oleyl-polysarcosine(45) // Sinónimos: (Z)-N-(octadec-9-en-1-yl) polysarcosineamide(45)
from 290,00 €
Nucleic acids have emerged in recent years as promising drug candidates for a wide range of diseases, as demonstrated by the development of mRNA vaccines to combat the Covid-19 pandemic. As nucleic acids are unable to pass physiological barriers, novel tools for packaging and delivery are required, especially since the frequently used polyethylene glycol may induce the generation of anti-PEG antibodies, leading to immunogenicity and allergic reactions. Iris Biotech offers a selection of innovative lipidated PSar and PGA-based polyamino acids for improved drug delivery.
SURPAX™ Technology (Surface Pacifying Excipient) was originally designed for protein stabilization but has found additional application as a shielding lipid in LNP formulations. This product shows superior properties for antibody and protein stability, does not impact binding, and maintains activities of mAB to targets. Biocompatibility has been tested vs body weight gain, vein tolerance, biochemical profile, and hematology.
US Patent 11,692,099